Organon & Co. (OGN)

US — Healthcare Sector
Peers: JNJ  BMY  ABBV  LLY  PFE  AMGN  MRK  GILD  SNY  AZN  NVS  BIIB 

Automate Your Wheel Strategy on OGN

With Tiblio's Option Bot, you can configure your own wheel strategy including OGN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol OGN
  • Rev/Share 24.4084
  • Book/Share 2.1019
  • PB 4.5388
  • Debt/Equity 16.524
  • CurrentRatio 1.6715
  • ROIC 0.1476

 

  • MktCap 2479980240.0
  • FreeCF/Share 2.5246
  • PFCF 3.8095
  • PE 3.28
  • Debt/Assets 0.6808
  • DivYield 0.0901
  • ROE 1.8171

 

  • Rating B+
  • Score 3
  • Recommendation Neutral
  • P/E Score 2
  • DCF Score 5
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Downgrade OGN Evercore ISI Outperform In-line -- -- May 2, 2025
Downgrade OGN JP Morgan Neutral Underweight $18 $20 Sept. 6, 2024

News

OGN Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Lawsuit Against Organon & Co.
OGN
Published: May 30, 2025 by: PRNewsWire
Sentiment: Neutral

SAN DIEGO , May 30, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Organon & Co. (NYSE: OGN) securities between October 31, 2024 and April 30, 2025. Organon is a global healthcare company with a primary focus on improving the health of women throughout their lives.

Read More
image for news OGN Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Lawsuit Against Organon & Co.
OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit
OGN
Published: May 30, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , May 30, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

Read More
image for news OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit
Lost Money on Organon & Co. (OGN)? Urged to Join Class Action Before July 22, 2025 - Contact Levi & Korsinsky
OGN
Published: May 30, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=151049&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

Read More
image for news Lost Money on Organon & Co. (OGN)? Urged to Join Class Action Before July 22, 2025 - Contact Levi & Korsinsky
OGN DEADLINE REMINDER: Organon & Co. Investors May Be Able to Recover Losses - Contact BFA Law by July 22 Class Action Deadline
OGN
Published: May 30, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / May 30, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE:OGN) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Organon you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/organon-co-class-action.

Read More
image for news OGN DEADLINE REMINDER: Organon & Co. Investors May Be Able to Recover Losses - Contact BFA Law by July 22 Class Action Deadline
Levi & Korsinsky Urges Organon (OGN) Shareholders to Act Before Lead Plaintiff Deadline July 22, 2025
OGN
Published: May 30, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=151034&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Urges Organon (OGN) Shareholders to Act Before Lead Plaintiff Deadline July 22, 2025
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
OGN
Published: May 30, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / May 30, 2025 / WHY: New York, N.Y., May 30, 2025.

Read More
image for news ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Did You Lose Money on Organon & Co. (OGN)? Levi & Korsinsky Urges Investors to Act Before July 22, 2025
OGN
Published: May 30, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=151028&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq.

Read More
image for news Did You Lose Money on Organon & Co. (OGN)? Levi & Korsinsky Urges Investors to Act Before July 22, 2025
Class Action Filed Against Organon & Co. (OGN) - July 22, 2025 Deadline to Join – Contact Levi & Korsinsky
OGN
Published: May 30, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit.

Read More
image for news Class Action Filed Against Organon & Co. (OGN) - July 22, 2025 Deadline to Join – Contact Levi & Korsinsky
Contact Levi & Korsinsky by July 22, 2025 to Join Class Action Against Organon & Co. (OGN)
OGN
Published: May 30, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=151019&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.

Read More
image for news Contact Levi & Korsinsky by July 22, 2025 to Join Class Action Against Organon & Co. (OGN)
Shareholders who lost money on Organon & Co. (NYSE: OGN). Should Contact Wolf Haldenstein
OGN
Published: May 30, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against Organon & Co. (NYSE: OGN) in the United States District Court for the District of New Jersey. Investors who acquired Organon shares during the class period are encouraged to contact the law firm before the lead plaintiff motion deadline on July 22, 2025.

Read More
image for news Shareholders who lost money on Organon & Co. (NYSE: OGN). Should Contact Wolf Haldenstein
Levi & Korsinsky Urges Organon & Co. (OGN) Shareholders to Act Before Lead Plaintiff Deadline July 22, 2025
OGN
Published: May 30, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=151003&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Urges Organon & Co. (OGN) Shareholders to Act Before Lead Plaintiff Deadline July 22, 2025
OGN Investors Have the Opportunity to Lead the Organon Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
OGN
Published: May 30, 2025 by: PRNewsWire
Sentiment: Neutral

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Organon To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Organon between October 31, 2024 and April 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , May 30, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Organon & Co. ("Organon" …

Read More
image for news OGN Investors Have the Opportunity to Lead the Organon Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OGN
OGN
Published: May 29, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 22, 2025.

Read More
image for news ROSEN, SKILLED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OGN
Securities Fraud Investigation Into Organon & Co. (OGN) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
OGN
Published: May 29, 2025 by: Business Wire
Sentiment: Neutral

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ORGANON & CO. (OGN), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On May 1, 2025,.

Read More
image for news Securities Fraud Investigation Into Organon & Co. (OGN) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Shareholders of Organon & Co. Should Contact The Gross Law Firm Before July 22, 2025 to Discuss Your Rights – OGN
OGN
Published: May 29, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN).

Read More
image for news Shareholders of Organon & Co. Should Contact The Gross Law Firm Before July 22, 2025 to Discuss Your Rights – OGN
Organon & Co. (OGN) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
OGN
Published: May 29, 2025 by: Business Wire
Sentiment: Neutral

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ORGANON & CO. (OGN), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at.

Read More
image for news Organon & Co. (OGN) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
OGN INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
OGN
Published: May 29, 2025 by: Business Wire
Sentiment: Neutral

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Organon business and prospects, resulting in its stock trading at inflated prices.

Read More
image for news OGN INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
OGN ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Organon & Co. - July 22, 2025 Deadline
OGN
Published: May 29, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 29, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=150669&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq.

Read More
image for news OGN ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Organon & Co. - July 22, 2025 Deadline
OGN SECURITIES ALERT: Organon & Co. Investors are Notified of the Pending Securities Fraud Class Action; Contact BFA Law if You Lost Money
OGN
Published: May 28, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE:OGN) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Organon you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/organon-co-class-action.

Read More
image for news OGN SECURITIES ALERT: Organon & Co. Investors are Notified of the Pending Securities Fraud Class Action; Contact BFA Law if You Lost Money
Rosen Law Firm Urges Organon & Co. (NYSE: OGN) Stockholders With Large Losses to Contact the Firm for Information About Their Rights
OGN
Published: May 28, 2025 by: Business Wire
Sentiment: Neutral

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers of Organon & Co. (NYSE: OGN) securities between October 31, 2024 and April 30, 2025, both dates inclusive (the “Class Period”). Organon is a healthcare company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Orga.

Read More
image for news Rosen Law Firm Urges Organon & Co. (NYSE: OGN) Stockholders With Large Losses to Contact the Firm for Information About Their Rights
Lost Money on Organon & Co. (OGN)? Join Class Action Before July 22, 2025 - Contact Levi & Korsinsky
OGN
Published: May 28, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=150577&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq.

Read More
image for news Lost Money on Organon & Co. (OGN)? Join Class Action Before July 22, 2025 - Contact Levi & Korsinsky
OGN Investors Have the Opportunity to Lead the Organon Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
OGN
Published: May 28, 2025 by: GlobeNewsWire
Sentiment: Neutral

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Organon To Contact Him Directly To Discuss Their Options

Read More
image for news OGN Investors Have the Opportunity to Lead the Organon Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Levi & Korsinsky Notifies Organon & Co. (OGN) Investors - Lead Plaintiff Deadline on July 22, 2025
OGN
Published: May 28, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=150566&wire=1&utm_campaign=14 or contact Joseph E. Levi, Esq.

Read More
image for news Levi & Korsinsky Notifies Organon & Co. (OGN) Investors - Lead Plaintiff Deadline on July 22, 2025
Investors in Organon & Co. (OGN): Protect Your Rights - Contact Levi & Korsinsky Before July 22, 2025
OGN
Published: May 27, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=150388&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.

Read More
image for news Investors in Organon & Co. (OGN): Protect Your Rights - Contact Levi & Korsinsky Before July 22, 2025
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Organon & Co. (OGN)
OGN
Published: May 27, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of all persons or entities who purchased or otherwise acquired Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) securities between October 31, 2024 through April 30, 2025, both dates inclusive (the “Class Period”).

Read More
image for news Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Organon & Co. (OGN)
Investors Urged to Contact Levi & Korsinsky for Information Before July 22, 2025 - Organon & Co. (OGN)
OGN
Published: May 26, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=150196&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq.

Read More
image for news Investors Urged to Contact Levi & Korsinsky for Information Before July 22, 2025 - Organon & Co. (OGN)
OGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Organon & Co. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
OGN
Published: May 26, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Organon & Co. ("Organon" or "the Company") (NYSE:OGN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Organon securities between October 31, 2024 and April 30, 2025, both dates inclusive (the "Class Period").

Read More
image for news OGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Organon & Co. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Lost Money on Organon & Co. (OGN)? Urged to Join Class Action Before July 22, 2025 - Contact Levi & Korsinsky
OGN
Published: May 25, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / May 25, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=150170&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

Read More
image for news Lost Money on Organon & Co. (OGN)? Urged to Join Class Action Before July 22, 2025 - Contact Levi & Korsinsky
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
OGN
Published: May 25, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, May 25, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Organon & Co. (“Organon” or “the Company”) (NYSE: OGN) and certain of its officers.

Read More
image for news OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
OGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Organon & Co. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
OGN
Published: May 23, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / May 23, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Organon & Co. ("Organon" or "the Company") (NYSE:OGN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Organon securities between October 31, 2024 and April 30, 2025, both dates inclusive (the "Class Period").

Read More
image for news OGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Organon & Co. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

About Organon & Co. (OGN)

  • IPO Date 2021-05-14
  • Website https://www.organon.com
  • Industry Drug Manufacturers - General
  • CEO Mr. Kevin Ali
  • Employees 10000

Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for various treatments to control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. In addition, the company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. The company sells its products primarily to drug wholesalers and retailers, hospitals, and government agencies, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was incorporated in 2020 and is based in Jersey City, New Jersey.